Roumell Asset Management, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 73 filers reported holding ENZO BIOCHEM INC in Q2 2021. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2023$1,253,699
-43.0%
681,358
-24.7%
2.46%
-50.5%
Q1 2023$2,199,908
-27.7%
905,312
-57.5%
4.98%
-33.9%
Q4 2022$3,043,418
-42.9%
2,128,264
-11.0%
7.54%
-34.7%
Q3 2022$5,330,000
+7.7%
2,390,2110.0%11.54%
+19.8%
Q2 2022$4,948,000
-28.7%
2,390,211
-0.1%
9.63%
-14.1%
Q1 2022$6,939,000
-11.3%
2,392,642
-1.8%
11.21%
+7.5%
Q4 2021$7,822,000
-23.5%
2,436,771
-15.6%
10.43%
-23.0%
Q3 2021$10,219,000
+11.7%
2,886,7710.0%13.54%
+26.6%
Q2 2021$9,151,000
-2.8%
2,886,771
+5.5%
10.69%
-21.5%
Q1 2021$9,414,000
+34.9%
2,736,719
-1.2%
13.61%
+24.1%
Q4 2020$6,979,000
+40.5%
2,769,479
+17.6%
10.97%
+11.4%
Q3 2020$4,968,000
+262.6%
2,354,479
+284.9%
9.85%
+198.2%
Q2 2020$1,370,000
-67.1%
611,764
-50.5%
3.30%
-66.5%
Q2 2019$4,166,000
-19.7%
1,236,309
-34.9%
9.86%
-21.8%
Q1 2019$5,185,000
+68.8%
1,899,179
+71.8%
12.61%
+98.7%
Q4 2018$3,072,000
-2.6%
1,105,139
+44.4%
6.35%
+9.7%
Q3 2018$3,153,000765,2845.79%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2021
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,736,719$9,414,00013.61%
HARBERT FUND ADVISORS, INC. 5,175,913$17,805,0008.40%
Evermore Global Advisors, LLC 2,605,607$8,963,0006.32%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$328,0000.19%
CORRADO ADVISORS, LLC 46,816$161,0000.12%
MYDA Advisors LLC 35,000$120,0000.03%
Cutter & CO Brokerage, Inc. 29,827$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 258,700$890,0000.02%
Paradigm Financial Partners, LLC 18,000$62,0000.02%
Renaissance Technologies 3,340,864$11,493,0000.01%
View complete list of ENZO BIOCHEM INC shareholders